Effects of sulfonylureas, α-endosulfine counterparts, on glomerulosclerosis in type 1 and type 2 models of diabetes

Kidney International

Volumn 67, Issue 2, 2005, Pages 554-565

  Biederman, Jason I ^b   Vera, Edgard ^b   Rankhaniya, Rohit ^b   Hassett, Clare ^b   Giannico, Giovanna ^b   Yee, Jerry ^b   Cortes, Pedro ^a  

^a HENRY FORD HOSPITAL   (United States)

^b NONE

Author keywords

Diabetic glomerulosclerosis; Endosulfine; Insulin deficiency; Sulfonylureas

Indexed keywords

DIMETHYL SULFOXIDE; GLIBENCLAMIDE; INSULIN; STREPTOZOCIN; SULFONYLUREA; TOLAZAMIDE;

ANALYSIS OF VARIANCE; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DILATATION; ARTICLE; CHEMICAL ANALYSIS; CONTROLLED STUDY; DIABETIC NEPHROPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXCRETION; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION; GLOMERULUS FILTRATION RATE; HISTOLOGY; HYPERGLYCEMIA; IMMUNOBLOTTING; INSULIN RESISTANCE; KIDNEY HYPERTROPHY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 12344284788     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.67112.x     Document Type: Article

References (75)

1. + channels: Generating excitement in pancreatic β-cells. Diabetes 45:845-853, 1996
2. + channel subunit Kir6.2 in mouse pancreas. Diabetes 46:1440-1444, 1997
3. ATP channels. Ann Rev Physiol 60:667-687, 1998
4. HIGGINS CF: The ABC of channel regulation. Cell 82:693-696, 1995
5. + channels. Science 268:372-373, 1995
6. BRIAN J, AGUILAR-BRIAN L: The ABCs of ATP-sensitive potassium channels-More pieces of the puzzle. Curr Opin Cell Biol 9:553-559, 1997
7. ATP channel as a receptor for potassium channel openers. J Biol Chem 271:8796-8799, 1996
8. + channels in mitochondria. Biochem Biophys Res Comm 241:693-697, 1997
9. ATP channels of the endocrine pancreas. Diabetes 52:767-776, 2003
10. ATP channels in cardioprotection against ischemia/reperfusion injury in mice. J Clin Invest 109:509-516, 2002
11. 3H-glibenclamide in pancreatic islet cells. Diabetologia 29:259-261, 1996
12. SCHWANSTECHER M, SCHWANSTECHER C, DICKEL C, et al: Location of the sulfonylurea receptor at the cytoplasmic face of the beta-cell membrane. Brit J Pharmacol 113:903-911, 1994
13. ZUNKLER BJ, TRUBE G, PANTEN U: How do sulfonylureas approach their receptor in the β-cell plasma membrane? Naunyn-Schmiedeberg's Arch Pharmacol 340:328-332, 1989
14. ASHCROFT SJH, ASHCROFT FM: The sulfonylurea receptor. Biochem Biophys Acta 1175:45-59, 1992
15. + channels. Neuron 16:1011-1017, 1996
16. ATP channels. Diabetes 45:1439-1445, 1996
17. + channel subunits Kir6.2 and SUR2A. J Mol Cell Cardiol 31:425-434, 1999
18. BEESLEY AH, QURESHI IZ, GIESBERTS AN, et al: Expression of sulphonylurea receptor protein in mouse kidney. Pflugers Arch-Eur J Physiol 438:1-7, 1999
19. ATP channel. Am J Physiol Renal Physiol 282:F289-F300, 2002
20. TANEMOTO M, VANOYE CG, DONG K, et al: Rat homolog of sulfonylurea receptor 2B determines glibenclamide sensitivity of ROMK2 in Xenopus laevis oocyte. Am J Physiol Renal Physiol 278:F659-F666, 2000
21. METZGER F, LOFfIER C, QUAST U: Sulfonylurea binding in rat isolated glomeruli: Pharmacological characterization and dependence on cell metabolism and cytoskeleton. Naunyn-Schmiedebergs Arch Pharmacol 355:141-149, 1997
22. + channels in the rabbit. J Clin Invest 90:733-740, 1992
23. + channels on afferent arteriolar diameter in diabetes mellitus. J Am Soc Nephrol 11:1199-1207, 2000
24. EDWARDS G, WESTON AH: The pharmacology of ATP-sensitive potassium channels. Ann Rev Pharmacol Toxicol 33:597-637, 1993
25. ASANO K, CORTES P, GARVIN JL, et al: Characterization of the rat mesangial cell type 2 sulfonylurea receptor. Kidney Int 55:2289-2298, 1999
26. + channel. Kidney Int 61:1739-1749, 2002
27. VIRSOLVY-VERGINE A, LERAY H, KUKORI S, et al: Endosulfine, an endogenous peptidic ligand for the sulfonylurea receptor: Purification and partial characterization from ovine brain. Proc Natl Acad Sci USA 89:6629-6633, 1992
28. VIRSOLVY-VERGINE A, SALAZAR G, SILLARD R, et al: Endosulfine, endogenous ligand for the sulphonylurea receptor: isolation from porcine brain and partial structural determination of the alpha form. Diabetologia 39:135-141, 1996
29. PEYROLLIER K, HERON L, VIRSOLVY-VERGINE A, et al: Alpha endosulfine is a novel molecule, structurally related to a family of phosphoproteins. Biochem Biophys Res Comm 223:583-586, 1996
30. HERON L, VIRSOLVY A, APIOU F, CAM A, et al: Isolation, characterization, and chromosomal localization of the human ENSA gene that encodes alpha-endosulfine, a regulator of beta-cell K (ATP) channels. Diabetes 48:1873-1876, 1999
31. DULUBOVA I, HORIUCHI A, SNYDER GL, et al: ARPP-16/ARPP-19: A highly conserved family of cAMP-regulated phosphoproteins. J Neurochem 77:229-238, 2001
32. IRWIN N, CHAO S, GORICHENKO L, et al: Nerve growth factor controls GAP-43 mRNA stability via the phosphoprotein ARPP-19. Proc Natl Acad Sci 99:12427-12431, 2002
33. BATAILLE D, HERON L, VIRSOLVY A, et al: α-Endosulfine, a new entity in the control of insulin secretion. Cell Mol Life Sci 56:78-84, 1999
34. GROS L, BREANT B, DUCHENE B, et al: Localization of α-endosulphine in pancreatic somatostatin δ cells and expression during rat pancreas development. Diabetologia 45:703-710, 2002
35. YEE J, CORTES P, BARNES J L, et al: Rat mesangial α-endosulfine. Kidney Int 65:1731-1739, 2004
36. WILKES BM, MENTO PF, VERNACE MA: Angiotensin responsiveness in hyperfiltering and nonhyperfiltering diabetic rats. J Am Soc Nephrol 4:1346-1353, 1993
37. STACKHOUSE S, MILLER PL, PARK SK, MEYER TW: Reversal of glomerular hyperfiltration and renal hypertrophy by blood glucose normalization in diabetic rats. Diabetes 39:989-995, 1999
38. PUGLIESE G, PRICCI F, PESCE C, et al: Early, but not advanced, glomerulopathy is reversed by pancreatic islet transplants in experimental diabetic rats. Diabetes 46:1198-1206, 1997
39. NAKAMURA T, TAKAHASHI T, FUKUI M, et al: Enalapril attenuates increased gene expression of extracellular matrix components in diabetic rats. J Am Soc Nephrol 5:1492-1497, 1995
40. ALLEN TJ, CAO Z, YOUSSEF S, et al: Role of angiotensin II and bradykinin in experimental diabetic nephropathy. Diabetes 46:1612-1618, 1997
41. BARCELLI UO, WEISS M, BEACH D, et al: High linoleic acid diets ameliorate diabetic nephropathy in rats. Am J Kidney Dis 16:244-251, 1990
42. ZATZ R, DUNN BD, MEYER TW, et al: Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 77:1925-1930, 1986
43. LEE SM, TUTWILER G, BRESSLER R, KIRCHER CH: Metabolic control and prevention of nephropathy by 2-tetradecylglycidate in the diabetic mouse (db/db). Diabetes 31:12-18, 1982
44. LEE SM: The effect of a high fibre diet on diabetic nephropathy in the db/db mouse. Diabetologia 22:349-354, 1982
45. KANG S-W, ADLER SG, NAST CC, et al: 12-lipoxygenase is increased in glucose-stimulated mesangial cells and in experimental diabetic nephropathy. Kidney Int 59:1354-1362, 2001
46. Recommendations for applying asymmetric amplification, in LightCycler Probe Design (catalogue number 3, 139174). August 2001, pp 63-64
47. EXNER M, LEWINSKI M: Sensitivity of multiplex real-time PCR reactions, using the LightCycler and the ABI PRISM 7700 Sequence Detection System, is dependent on the concentration of the DNA polymerase. Mol Cell Probes 16:351-357, 2002
48. BIEDERMAN J, YEE J, CORTES P: Validation of internal control genes for gene expression analysis in diabetic glomerulosclerosis. Kidney Int (in press)
49. JOBIN J, BONJOUR J-P: Measurement of glomerular filtration rate in conscious unrestrained rats with inulin infused by implanted osmotic pumps. Am J Physiol 248 (Renal Fluid Electrolyte Physiol 77):F734-F738, 1985
50. LORENZ JN, GRUENSTEIN E: A simple, nonradioactive method for evaluating single-nephron filtration rate using FITC-inulin. Am J Physiol 276 (Renal Physiol 45):F172-F177, 1999
51. EL NAHAS AM, BASSET AH, COPE GH, LE CARPENTIER JE: Role of growth hormone in the development of experimental renal scarring. Kidney Int 40:29-34, 1991
52. SHROUT PE, FLEISS JL: Intraclass correlations: Uses in assessing rater reliability. Psychol Bull 86:420-428, 1979
53. GREIVE KA, EPPEL GA, REEVE S, et al: Immuno-unreactive albumin excretion increases in streptozotocin diabetic rats. Am J Kidney Dis 38:144-152, 2001
54. CHIOU WL, ROBBIE G, CHUNG SM, et al: Correlation of plasma clearance of 54 extensively metabolized drugs between humans and rats: Mean allometric coefficient of 0.66. Pharmaceutical Res 15:1474-1479, 1998
55. UPJOHN COMPANY REPORT: Tolinase. Official Lit New Drugs 10:423-427, 1965
56. FUJIHARA CK, PADILHA RM, ZATZ R: Glomerular abnormalities in long-term experimental diabetes. Role of hemodynamic and non-hemodynamic factors and effects of antihypertensive therapy. Diabetes 41:286-293, 1992
57. RETMUZZI A, PERICO N, AMUCHASTEGUI CS, et al: Short- and long-term effect of angiotensin II receptor blockade in rats with experimental diabetes. J Am Soc Nephrol 4:40-49, 1993
58. CORTES P, ZHAO X, DUMLER F, et al: Age-related changes in glomerular volume and hydroxyproline content in rat and human. J Am Soc Nephrol 2:1760-1725, 1992
59. VLASSARA H: Protein glycation in the kidney: Role in diabetes and aging. Kidney Int 49:1795-1804, 1996
60. ANDERSON S, RENNKE HG, ZATZ R: Glomerular adaptations with normal aging and with long-term converting enzyme inhibition in rats. Am J Physiol 267 (Renal Fluid Electrolyte Physiol 36):F35-F43, 1994
61. BAYLIS C: Age-dependent glomerular damage in the rat. Dissociation between glomerular injury and both glomerular hypertension and hypertrophy. Male gender as a primary risk factor. J Clin Invest 94:1823-1829, 1994
62. CORTES P, ZHAO X, RISER BL, NARINS RG: Role of glomerular mechanical strain in the pathogenesis of diabetic nephropathy. Kidney Int 51:557-568, 1997
63. RISER BL, CORTES P, YEE J, et al: Mechanical strain- and high glucose-induced alterations in mesangial cell collagen metabolism: role of TGF-β. J Am Soc Nephrol 9:827-836, 1998
64. ALLEN TJ, WALDRON MJ, CASLEY D, et al: Salt restriction reduces hyperfiltration, renal enlargement, and albuminuria in experimental diabetes. Diabetes 46:119-124, 1997
65. TUCKER BJ, COLLINS RC, ZIEGLER MG, BLANTZ RC: Disassociation between glomerular hyperfiltration and extracellular volume in diabetic rats. Kidney Int 39:1176-1183, 1991
66. ANDERSON S, MEYER TW, RENNKE HG, BRENNER BM: Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest 76:612-619, 1985
67. BARBOSA J, STEFFES MW, SUTHERLAND DER, et al: Effect of glycemic control on early diabetic renal lesions. A 5-year randomized controlled clinical trial of insulin-dependent diabetic kidney transplant recipients. JAMA 272:600-606, 1994
68. RUDBERG S, PERSSON B, DAHLQUIST G: Increased glomerular filtration rate as a predictor of diabetic nephropathy. An 8-year prospective study. Kidney Int 41:822-828, 1992
69. YIP JW, JONES SL, WISEMAN MJ, et al: Glomerular hyperfiltration in the prediction of nephropathy in IDDM. A 10-year follow-up study. Diabetes 45:1729-1733, 1996
70. SHARMA K, ZIYADEH FN: Renal hypertrophy is associated with upregulation of TGF-β1 gene expression in diabetic BB rat and NOD mouse. Am J Physiol 267 (Renal Fluid Electrolyte Physiol 36):F1094-F1101, 1994
71. SHANKLAND SJ, SCHOLEY JW: Expression of growth-related protooncogenes during diabetic renal hypertrophy. Kidney Int 47:782-788, 1995
72. DERUBERTIS FR, CRAVEN PA: Activation of protein kinase C in glomerular cells in diabetes. Mechanisms and potential links to the pathogenesis of diabetic glomerulopathy. Diabetes 43:1-8, 1994
73. WILMER WA, DIXON CL, HEBERT C: Chronic exposure of human mesangial cells to high glucose environments activates the p38 MAPK pathway. Kidney Int 60:858-871, 2001
74. UK PROSPECTIVE DIABETES STUDY (UKPDS) GROUP: Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853, 1998
75. TURNER RC: The U.K. Prospective Diabetes Study. A review. Diabetes Care 21: C35-C38, 1998